ACP-01, autologous angiogenic precursor cells for critical limb ischemia
ACP-01 is a product comprised of autologous angiogenic peripheral blood-derived precursor cells, expanded ex vivo for the treatment of critical limb ischemia. The treatment was found to be safe in a small-scale clinical trial and improved circulation in patients.
Read More
Product Information for
ACP-01, autologous angiogenic precursor cells for critical limb ischemia
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access